Douglas Laboratories Relora-Plex
Relora®-Plex is a unique proprietary blend that combines two herbal extracts, Magnolia and Phellodendron, with B-vitamins to support normal mental functioning during stress. Relora® was shown in published clinical studies to support normal salivary cortisol levels, stress, mood and weight management.
Each serving contains:
Thiamine - 10 mg
Riboflavin - 10 mg
Niacinamide - 10 mg
Vitamin B6 - 10 mg
Folic Acid - 200 mcg
Vitamin B12 - 100 mcg
Relora® - 500 mg
Other ingredients: Cellulose and vegetable stearate.
Relora® is a registered trademark of NPI, LLC.
√U.S. Patent No. US 6,582,735.
As a dietary supplement, adults take 2 capsules daily or as directed by your healthcare professional.
Cortisol, a hormone produced in the adrenal glands, plays an important role in the body’s regulation of cardiovascular function and fat, protein and carbohydrate utilization. When the body experiences stress, cortisol secretion increases, thus causing a breakdown of muscle protein and the release of amino acids to form glucose via gluconeogenesis. The resulting higher level of glucose in the body, combined with the decreased use of glucose by other tissues in the body, ensures that the brain is receiving adequate energy. Continuing research indicates that stress and anxiety can have a significant impact on the body’s health and wellbeing.
While cortisol secretion is an important part of the body’s response to stress, the prolonged secretion of cortisol can have detrimental effects to the proper functioning of the body’s cardiovascular, immune, neurological and metabolic systems. Relora® is a patent-pending combination of two herbal extracts of Magnolia and Phellodendron bark (Asian cork tree). Both herbs have been used in Traditional Chinese Medicine for several hundred years. In a human study, 82% of the participants taking Relora® agreed with the statement that: “Relora® helps control…. irritability, emotional ups and downs, restlessness, tense muscles, poor sleep, fatigue, and concentration difficulties.” Relora® was found not to cause sedation, though 74% of the patients had more restful sleep. Additionally, no adverse side effects were reported during the trial. A second human trial studied the effects of Relora® on salivary dehydroepistandrosterone (DHEA) and cortisol levels in patients with mild to moderate stress. The effects of stress on the body are sometimes associated with lower levels of DHEA and higher levels of cortisol. Two weeks of Relora® increased salivary DHEA by 227% and decreased total salivary cortisol by 37%. Both hormones were brought into the normal range.